Breaking News

Tuesday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
MRK

Merck

$65.99

-0.17 (-0.26%)

, ZYME

Zymeworks

$7.93

0.28 (3.66%)

05:51
09/19/17
09/19
05:51
09/19/17
05:51
Hot Stocks
Merck to advance bispecific drug candidate developed using Zymeworks Azymetric »

Zymeworks (ZYME)…

MRK

Merck

$65.99

-0.17 (-0.26%)

ZYME

Zymeworks

$7.93

0.28 (3.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 30

    Nov

Monday
ABBV

AbbVie

$87.37

-1.85 (-2.07%)

, BAYRY

Bayer

$131.85

-1.51 (-1.13%)

06:57
09/18/17
09/18
06:57
09/18/17
06:57
Recommendations
AbbVie, Bayer, Zoetis, Bristol-Myers, Eli Lilly, Merck, Novo Nordisk analyst commentary at Jefferies »

AbbVie remains top global…

ABBV

AbbVie

$87.37

-1.85 (-2.07%)

BAYRY

Bayer

$131.85

-1.51 (-1.13%)

ZTS

Zoetis

$65.20

-0.05 (-0.08%)

BMY

Bristol-Myers

$62.48

-0.21 (-0.33%)

LLY

Eli Lilly

$82.44

-0.63 (-0.76%)

MRK

Merck

$66.16

0.04 (0.06%)

NVO

Novo Nordisk

$48.19

-0.46 (-0.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 20

    Sep

  • 21

    Sep

  • 22

    Sep

  • 24

    Sep

  • 25

    Sep

  • 27

    Sep

  • 18

    Oct

  • 26

    Oct

  • 09

    Nov

  • 05

    Mar

Over a week ago
SSNLF

Samsung

, BIIB

Biogen

$323.66

-0.39 (-0.12%)

07:50
09/15/17
09/15
07:50
09/15/17
07:50
Hot Stocks
Samsung Bioepis receives positive CHMP opinion on trastuzumab biosimilar »

Samsung Bioepis (SSNLF,…

SSNLF

Samsung

BIIB

Biogen

$323.66

-0.39 (-0.12%)

RHHBY

Roche

$31.60

0.11 (0.35%)

MRK

Merck

$66.12

1.14 (1.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 30

    Nov

AAPL

Apple

$161.50

2.87 (1.81%)

, SNAP

Snap

$15.27

-0.07 (-0.46%)

07:35
09/12/17
09/12
07:35
09/12/17
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

AAPL

Apple

$161.50

2.87 (1.81%)

SNAP

Snap

$15.27

-0.07 (-0.46%)

TEVA

Teva

$18.50

3 (19.35%)

F

Ford

$11.41

0.05 (0.44%)

TGT

Target

$57.29

0.02 (0.03%)

HIMX

Himax

$11.31

1.12 (10.99%)

MRK

Merck

$65.13

0.86 (1.34%)

PG

Procter & Gamble

$93.99

1.15 (1.24%)

MYL

Mylan

$33.04

0.94 (2.93%)

BHP

BHP Billiton

$43.70

0.71 (1.65%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

  • 13

    Sep

  • 22

    Sep

  • 27

    Sep

  • 27

    Sep

  • 09

    Oct

  • 03

    Dec

MRK

Merck

$65.15

0.875 (1.36%)

11:40
09/11/17
09/11
11:40
09/11/17
11:40
Options
Timely morning call buyers in Merck »

Timely morning call…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Sep

  • 22

    Sep

SNY

Sanofi

, HCA

HCA Holdings

09:40
09/11/17
09/11
09:40
09/11/17
09:40
Options
Unusually active option classes on open September 11th »

Unusual total active…

SNY

Sanofi

HCA

HCA Holdings

DWDP

DowDuPont

TMUS

T-Mobile

$62.74

-0.6 (-0.95%)

MYL

Mylan

$32.10

0.19 (0.60%)

KORS

Michael Kors

MRK

Merck

TEVA

Teva

LULU

lululemon

$62.34

1.04 (1.70%)

HD

Home Depot

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Sep

  • 12

    Sep

  • 22

    Sep

  • 27

    Sep

  • 27

    Sep

  • 03

    Oct

  • 04

    Oct

  • 09

    Oct

MRK

Merck

$64.27

-0.05 (-0.08%)

09:08
09/11/17
09/11
09:08
09/11/17
09:08
Hot Stocks
Merck updates data from Phase 3 study of KEYTRUDA »

Merck announced results…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Sep

  • 22

    Sep

INCY

Incyte

$129.46

-4.88 (-3.63%)

, MRK

Merck

$64.27

-0.05 (-0.08%)

07:48
09/11/17
09/11
07:48
09/11/17
07:48
Recommendations
Incyte, Merck analyst commentary at BMO Capital »

Incyte trial result…

INCY

Incyte

$129.46

-4.88 (-3.63%)

MRK

Merck

$64.27

-0.05 (-0.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Sep

  • 22

    Sep

NLNK

NewLink Genetics

$17.67

4.07 (29.93%)

, INCY

Incyte

$129.46

-4.88 (-3.63%)

07:23
09/11/17
09/11
07:23
09/11/17
07:23
Recommendations
NewLink Genetics, Incyte, Merck analyst commentary at Stifel »

NewLink Genetics price…

NLNK

NewLink Genetics

$17.67

4.07 (29.93%)

INCY

Incyte

$129.46

-4.88 (-3.63%)

MRK

Merck

$64.27

-0.05 (-0.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Sep

  • 22

    Sep

  • 25

    Sep

MRK

Merck

$64.27

-0.05 (-0.08%)

07:09
09/11/17
09/11
07:09
09/11/17
07:09
Hot Stocks
Merck enters into strategic collaboration with Project Data Sphere »

Merck announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Sep

  • 22

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.